Analysis of the respiratory effects of cannabinoids in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 4, 2003, Pages 301-308

  Schmid, Karin ^a   Niederhoffer, Nathalie ^a   Szabo, Bela ^a  

^a Inst Experimentelle Klin P   (Germany)

Author keywords

9 Tetrahydrocannabinol; Anaesthetised rats; Blood pressure; Cannabinoid receptor; Heart rate; Plasma noradrenaline; Respiratory regulation

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DRONABINOL; METHYLATROPINE; NORADRENALIN; RIMONABANT; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; ENANTIOMER; HEART RATE; HOMEOSTASIS; NEUROMODULATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; RAT; RESPIRATION CONTROL;

ANESTHESIA; ANIMALS; ATROPINE DERIVATIVES; BLOOD PRESSURE; CANNABINOIDS; CYCLOHEXANOLS; DEPRESSION, CHEMICAL; HEART RATE; HEMODYNAMIC PROCESSES; MORPHOLINES; MUSCARINIC AGONISTS; NAPHTHALENES; NOREPINEPHRINE; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS; TETRAHYDROCANNABINOL;

EID: 0242643754     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0787-3     Document Type: Article

References (44)

1. Calignano A, Katona I, Désarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408:96-101
2. Carruba MO, Bondiolotti G, Picotti GB, Catteruccia N, Da Prada M (1987) Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol 134: 15-24
3. 9-trans-tetrahydrocannabinol. Res Comm Chem Pathol Pharmacol 3:483-492
4. Compton DR, Harris LS, Lichtman AH, Martin BR (1996) Marihuana. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 83-158
5. Davidson NS, Glodner S, McCloskey DI (1976) Respiratory modulation of baroreceptor and chemoreceptor reflexes affecting heart rate and cardiac vagal efferent nerve activity. J Physiol 259:523-530
6. De Burgh Daly M, Hazzledine JL (1963) The effects of artificially induced hyperventilation on the primary cardiac reflex response to stimulation of the carotid bodies in the dog. J Physiol 168:872-889
7. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178
8. 9-tetrahydrocannabinol in anesthetized cats. J Pharmacol Exp Ther 227:508-516
9. 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci 41:79-87
10. 2 receptors. Mol Pharmacol 48:443-450
11. Gilbey MP, Jordan D, Richter DW, Spyer KM (1984) Synaptic mechanisms involved in the inspiratory modulation of vagal cardio-inhibitory neurones in the cat. J Physiol 356:65-78
12. Graham JDP, Li DMF (1973) Cardiovascular and respiratory effects of cannabis in cat and rat. Br J Pharmacol 49:1-10
13. Haymet BT, McCloskey DI (1975) Baroreceptor and chemoreceptor influences on heart rate during the respiratory cycle in the dog. J Physiol 245:699-712
14. Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ (1992) Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther 52:31-41
15. 1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028
16. 9-tetrahydrocannabinol with oxymorphone or pentobarbital: effects on ventilatory control and cardiovascular dynamics. Anesthesiology 42:674-684
17. Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner JA (2000) Cardiovascular effects of endocannabinoids-the plot thickens. Prostaglandins Other Lipid Meiat 61:71-84
18. 1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-1037
19. Lake KD, Martin BR, Kunos G, Varga K (1997b) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29:1204-1210
20. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedebergs Arch Pharmacol 356:197-202
21. 1 receptor. Naunyn-Schmiedebergs Arch Pharmacol 364:233-241
22. 9-tetrahydrocannabinol: effects on ventilatory control and cardiovascular dynamics. Anesthesiology 42: 666-673
23. Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38:45-74
24. Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE (1992) Regional cerebral blood flow after Marijuana smoking. J Cereb Blood Flow Metab 12:750-758
25. 9-tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects. Life Sci 19:99-104
26. Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457-466
27. Niederhoffer N, Szabo B (2000) Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther 294:707-713
28. Niederhoffer N, Hansen HH, Fernandez-Ruiz JJ, Szabo B (2001) Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br J Pharmacol 134:1319-1327
29. Niederhoffer N, Schmid K, Szabo B (2003) The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn-Schmiedebergs Arch Pharmacol 367:434-443
30. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-664
31. 9-tetrahydrocannabinol in rats and mice. Proc Soc Exp Biol Med 136: 260-263
32. 9-tetrahydrocannabinol in Fischer rats. Toxicol Appl Pharmacol 28:18-27
33. Rothe CF, Maass-Moreno R, Flanagan AD (1990) Effects of hypercapnia and hypoxia on the cardiovascular system: vascular capacitance and aortic chemoreceptors. Am J Physiol 259:H932-H939
34. Schläfke ME, Koepchen HP (1996) A systems view of respiratory regulation. In: Greger R, Windhorst U (eds) Comprehensive human physiology. Springer, Berlin Heidelberg New York, pp 2097-2127
35. Showalter VM, Compton DR, Martin BR, Abood MA (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999
36. Szabo B, Fritz T, Wedzony K (2001a) Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Br J Pharmacol 134:295-304
37. Szabo B, Nordheim U, Niederhoffer N (2001b) Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. J Pharmacol Exp Ther 297:819-826
38. Szabo B, Pfitzer T, Niederhoffer N (2002) Central respiratory effects of cannabinoids in rats [abstract]. 2002 Symposium on the Cannabinoids, International Cannabinoid Research Society, Burlington, Vermont, p 157
39. Taylor EW, Jordan D, Coote JH (1999) Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. Physiol Rev 79:855-916
40. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283
41. Varga K, Lake K, Huangfu D, Guyenet PG, Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682-686
42. 8-tetrahydrocannabinol-dimethylheptyl in rats. J Cardiovasc Pharmacol 28:332-336
43. Vivian JA, Kishioka S, Butelman ER, Broadbear J, O'Lee K, Woods JH (1998) Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in Rhesus monkeys: antagonist effects of SR141716A. J Pharmacol Exp Ther 286:697-703
44. Wagner JA, Varga K, Kunos G (1998) Cardiovascular actions of cannabinoids and their generation during shock. J Mol Med 76:824-836